Han Bao

No. 155 Nanjing North Road
Shenyang, 110001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Hyaluronic acid-modified polymeric nanoplatform delivering 131I-Hyp suppresses post-ablation residual lesions in colorectal cancer metastases via necrosis-targeted radiotherapy.

Hyaluronic acid-modified polymeric nanoplatform delivering 131I-Hyp suppresses post-ablation residual lesions in colorectal cancer metastases via necrosis-targeted radiotherapy.

Journal: Journal of pharmaceutical analysis

Published: June 23, 2025

MODA: a graph convolutional network-based multi-omics integration framework for unraveling hub molecules and disease mechanisms.

MODA: a graph convolutional network-based multi-omics integration framework for unraveling hub molecules and disease mechanisms.

Journal: Briefings in bioinformatics

Published: February 24, 2025

Applications of Biodegradable Polymeric Nanomaterials as Drug Delivery Systems.

Applications of Biodegradable Polymeric Nanomaterials as Drug Delivery Systems.

Journal: Current drug delivery

Published: February 11, 2025

Long Noncoding RNAs MALAT1 and HOTTIP Act as Serum Biomarkers for Hepatocellular Carcinoma.

Long Noncoding RNAs MALAT1 and HOTTIP Act as Serum Biomarkers for Hepatocellular Carcinoma.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: September 11, 2024

Comparison of the Effectiveness of Inguinal Lymphangiography and Transjugular Intrahepatic Portosystemic Shunt Creation in Cirrhosis-Related Chylous Ascites.

Comparison of the Effectiveness of Inguinal Lymphangiography and Transjugular Intrahepatic Portosystemic Shunt Creation in Cirrhosis-Related Chylous Ascites.

Journal: Journal of vascular and interventional radiology : JVIR

Published: July 06, 2024

Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation.

Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation.

Journal: Molecular pharmaceutics

Published: March 07, 2024

Invasive treatment of persistent postoperative chylothorax secondary to thoracic duct variation injury: Two case reports and literature review.

Invasive treatment of persistent postoperative chylothorax secondary to thoracic duct variation injury: Two case reports and literature review.

Journal: Medicine

Published: November 01, 2022

Factors affecting hemostasis in the control of iatrogenic renal hemorrhage.

Factors affecting hemostasis in the control of iatrogenic renal hemorrhage.

Journal: World journal of urology

Published: December 07, 2021

Therapeutic efficacy of novel microwave-sensitized mPEG-PLGA@ZrO2@(DOX + ILS) drug-loaded microspheres in rabbit VX2 liver tumours.

Therapeutic efficacy of novel microwave-sensitized mPEG-PLGA@ZrO2@(DOX + ILS) drug-loaded microspheres in rabbit VX2 liver tumours.

Journal: Nanoscale

Published: February 25, 2017

Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.

Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.

Journal: BioMed research international

Published: December 04, 2016

Tumor Thermal Ablation Enhancement by Micromaterials.

Tumor Thermal Ablation Enhancement by Micromaterials.

Journal: Current drug delivery

Published: September 02, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026